BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25546207)

  • 1. Is there a role for PET/CT with esophagogastric junction adenocarcinoma?
    Fuster D; Mayoral M; Rubello D; Pineda E; Fernández-Esparrach G; Pagès M; Colletti PM; Pons F
    Clin Nucl Med; 2015 Mar; 40(3):e201-7. PubMed ID: 25546207
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Lehmann K; Eshmuminov D; Bauerfeind P; Gubler C; Veit-Haibach P; Weber A; Abdul-Rahman H; Fischer M; Reiner C; Schneider PM
    Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
    Papaxoinis G; Weaver JMJ; Khoja L; Patrao A; Stamatopoulou S; Alchawaf A; Owen-Holt V; Germetaki T; Kordatou Z; Mansoor W
    Acta Oncol; 2017 Sep; 56(9):1224-1232. PubMed ID: 28524708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma.
    Sánchez-Izquierdo N; Perlaza P; Pagès M; Buxó E; Rios J; Rubello D; Colletti PM; Mayoral M; Casanueva S; Fernández-Esparrach G; Ginés A; Fuster D
    Clin Nucl Med; 2020 Jan; 45(1):38-43. PubMed ID: 31714278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
    Bjerring OS; Hess S; Petersen H; Fristrup CW; Lundell L; Mortensen MB
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33688946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
    Sihvo EI; Räsänen JV; Knuuti MJ; Minn HR; Luostarinen ME; Viljanen T; Färkkilä MA; Salo JA
    J Gastrointest Surg; 2004 Dec; 8(8):988-96. PubMed ID: 15585386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction.
    Sendler A
    Recent Results Cancer Res; 2010; 182():167-77. PubMed ID: 20676880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of 18F-FDG-PET testing in the management of esophageal and gastroesophageal junction adenocarcinoma - review.
    Zemanová M; Obermannová R; Haruštiak T
    Klin Onkol; 2021; 34(2):113-119. PubMed ID: 33906359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of (18)flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma.
    Smith JW; Moreira J; Abood G; Aranha GV; Nagda S; Wagner RH; Shoup M
    Am J Surg; 2009 Mar; 197(3):308-12. PubMed ID: 19245906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET-CT Post-Hepatic Radiation Changes in Gastroesophageal Adenocarcinoma.
    Nguyen D; Maheshwary R; Rajput A; Tran C; Kudithipudi V
    Clin Nucl Med; 2017 Jan; 42(1):e54-e55. PubMed ID: 27749425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.
    Ott K; Weber WA; Fink U; Helmberger H; Becker K; Stein HJ; Müller J; Schwaiger M; Siewert JR
    World J Surg; 2003 Sep; 27(9):1035-9. PubMed ID: 12917760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorodeoxyglucose-positron emission tomography in carcinoma of the esophagogastric junction].
    Wang T; Sun YE; Chu XY; Tian JH; Liu Y
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):651-3. PubMed ID: 15329251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review.
    Wong WL; Chambers RJ
    Abdom Imaging; 2008; 33(2):183-90. PubMed ID: 17619927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer.
    Paudel N; Kunz PL; Poultsides GA; Koong AC; Chang DT
    Pract Radiat Oncol; 2014; 4(6):368-71. PubMed ID: 25407856
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
    Weber MA; Bender K; von Gall CC; Stange A; Grünberg K; Ott K; Haberkorn U; Kauczor HU; Zechmann C
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):45-52. PubMed ID: 23539390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases.
    Ida S; Watanabe M; Yamao T; Ishimoto T; Nagai Y; Iwatsuki M; Baba Y; Iwagami S; Sakamoto Y; Miyamoto Y; Baba H
    Surg Today; 2014 Nov; 44(11):2191-4. PubMed ID: 24906431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer.
    Amrane K; Thuillier P; Bourhis D; Le Meur C; Quere C; Leclere JC; Ferec M; Jestin-Le Tallec V; Doucet L; Alemany P; Salaun PY; Metges JP; Schick U; Abgral R
    Sci Rep; 2023 Apr; 13(1):5789. PubMed ID: 37031233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy.
    Stagg J; Farukhi I; Lazaga F; Thompson C; Bradshaw L; Kaif M; Gould-Simon A; Schmidt R
    Dig Dis Sci; 2015 May; 60(5):1335-42. PubMed ID: 25502332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.